4D Molecular Therapeutics...

NASDAQ: FDMT · Real-Time Price · USD
7.39
0.29 (4.08%)
At close: Aug 15, 2025, 1:15 PM

4D Molecular Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
37K 20.72M 3.13M 18.04M
Cost of Revenue
6.71M 97.1M 3.88M 3.02M
Gross Profit
37K -76.37M -751K 15.02M
Operating Income
-187.84M -112.87M -110.03M -71.33M
Interest Income
27.05M 12.21M 2.57M 137K
Pretax Income
-160.87M -100.84M -107.49M -71.32M
Net Income
-160.87M -100.84M -101.08M -68.3M
Selling & General & Admin
46.58M 36.49M 32.91M 28.01M
Research & Development
141.3M 97.1M 80.25M 61.36M
Other Expenses
n/a n/a 2.54M 16K
Operating Expenses
187.88M 133.59M 113.16M 89.37M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
187.88M 133.59M 113.16M 89.37M
Income Tax Expense
n/a n/a -6.42M -3.02M
Shares Outstanding (Basic)
53.94M 39.13M 32.35M 27.73M
Shares Outstanding (Diluted)
53.94M 39.13M 32.35M 27.73M
EPS (Basic)
-2.98 -2.58 -3.12 -2.46
EPS (Diluted)
-2.98 -2.58 -3.12 -2.46
EBITDA
-187.84M -107.12M -106.15M -68.31M
EBIT
-187.84M -112.87M -110.03M -71.33M
Depreciation & Amortization
6.71M 5.75M 3.88M 3.02M